HALL EUGENE A

SEC source: 0001127602-23-017608 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,156,760

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective September 1, 2021) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-23-017247 · form4.xml · derivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,329 shares

Expires 2025-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 8, 2019 and are fully exercisable.

SEC source: 0001127602-23-017247 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,156,742

F3 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-23-017247 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,163,916

F2 · shares: Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs.

SEC source: 0001127602-23-017247 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,173,013

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of SARs.

SEC source: 0001127602-23-008432 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,145,684

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective September 1, 2021) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-23-006254 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,145,665

F2 · price: This transaction was executed in multiple trades at prices ranging from $351.02 to $351.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-006254 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,147,569

F1 · price: This transaction was executed in multiple trades at prices ranging from $350.00 to $350.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-005599 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,151,269

F2 · price: This transaction was executed in multiple trades at prices ranging from $351.02 to $351.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-005599 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,154,635

F1 · price: This transaction was executed in multiple trades at prices ranging from $350.00 to $350.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-004971 · form4.xml · derivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,876

Underlying: Common Stock · 20,939 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 10, 2022. This represents the 2023 installment.

F1 · derivative.expiration_date: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 10, 2022. This represents the 2023 installment.

SEC source: 0001127602-23-004971 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,160,076

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-23-004971 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,169,220

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 10, 2022. This represents the 2023 installment.

SEC source: 0001127602-23-004549 · form4.xml · derivative · entry 8

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,585

Underlying: Common Stock · 9,196 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents shares acquired upon the vesting of the first installment of the RSUs noted in footnote 7 on February 9, 2023. The RSUs convert into common stock on a one-for-one basis.

F1 · derivative.expiration_date: Represents shares acquired upon the vesting of the first installment of the RSUs noted in footnote 7 on February 9, 2023. The RSUs convert into common stock on a one-for-one basis.

SEC source: 0001127602-23-004549 · form4.xml · derivative · entry 7

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,781

Underlying: Common Stock · 36,781 shares

Expires not disclosed

F7 · derivative.exercise_date: These performance-based RSUs were awarded on February 9, 2022 and vest in four substantially equal annual installments, commencing on February 9, 2023. This represents the actual number of RSUs awarded after the performance metric was certified.

F7 · derivative.expiration_date: These performance-based RSUs were awarded on February 9, 2022 and vest in four substantially equal annual installments, commencing on February 9, 2023. This represents the actual number of RSUs awarded after the performance metric was certified.

SEC source: 0001127602-23-004549 · form4.xml · nonDerivative · entry 6

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,148,281

F6 · price: This transaction was executed in multiple trades at prices ranging from $352.36 to $353.31. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-004549 · form4.xml · nonDerivative · entry 5

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,150,512

F5 · price: This transaction was executed in multiple trades at prices ranging from $351.33 to $352.29. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-004549 · form4.xml · nonDerivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,153,439

F4 · price: This transaction was executed in multiple trades at prices ranging from $350.28 to $351.26. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-004549 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,164,501

F3 · price: This transaction was executed in multiple trades at prices ranging from $350.13 to $350.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-004549 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,164,691

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-23-004549 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,168,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon the vesting of the first installment of the RSUs noted in footnote 7 on February 9, 2023. The RSUs convert into common stock on a one-for-one basis.

SEC source: 0001127602-23-004971 · form4.xml · derivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,324

Underlying: Common Stock · 31,324 shares

Expires 2030-02-09

F3 · shares: These SARs become exercisable in four substantially equal annual installments, commencing on February 9, 2024.

F3 · derivative.exercise_date: These SARs become exercisable in four substantially equal annual installments, commencing on February 9, 2024.

SEC source: 0001127602-23-003830 · form4.xml · derivative · entry 6

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,357 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 6, 2020. This represents the 2023 installment.

F3 · derivative.exercise_date: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 6, 2020. This represents the 2023 installment.

F3 · derivative.expiration_date: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 6, 2020. This represents the 2023 installment.

SEC source: 0001127602-23-003830 · form4.xml · nonDerivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,159,704

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-23-003830 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,167,314

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 6, 2020. This represents the 2023 installment.

SEC source: 0001127602-23-003830 · form4.xml · derivative · entry 5

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,195

Underlying: Common Stock · 11,195 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 5, 2021. This represents the 2023 installment.

F1 · derivative.exercise_date: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 5, 2021. This represents the 2023 installment.

F1 · derivative.expiration_date: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 5, 2021. This represents the 2023 installment.

SEC source: 0001127602-23-003830 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,149,957

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-23-003830 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,154,489

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 5, 2021. This represents the 2023 installment.

SEC source: 0001127602-22-026813 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,143,294

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective September 1, 2021) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-22-024972 · form4.xml · nonDerivative · entry 7

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,143,277

F7 · price: This transaction was executed in multiple trades at prices ranging from $327.42 to $328.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-024972 · form4.xml · nonDerivative · entry 6

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,143,877

F6 · price: This transaction was executed in multiple trades at prices ranging from $326.38 to $327.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-024972 · form4.xml · nonDerivative · entry 5

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,147,477

F5 · price: This transaction was executed in multiple trades at prices ranging from $325.31 to $326.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-024972 · form4.xml · nonDerivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,151,583

F4 · price: This transaction was executed in multiple trades at prices ranging from $324.22 to $325.18. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-024972 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,155,567

F3 · price: This transaction was executed in multiple trades at prices ranging from $323.04 to $324.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-024972 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,156,567

F2 · price: This transaction was executed in multiple trades at prices ranging from $321.81 to $322.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-024972 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,159,034

F1 · price: This transaction was executed in multiple trades at prices ranging from $320.76 to $321.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-022023 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,159,929

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective September 1, 2021) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-22-020604 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,159,908

F2 · price: This transaction was executed in multiple trades at prices ranging from $290.09 to $290.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-020604 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,167,041

F1 · price: This transaction was executed in multiple trades at prices ranging from $293.92 to $294.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-016441 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,177,466

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective September 1, 2021) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-22-015891 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,177,443

F1 · price: This transaction was executed in multiple trades at prices ranging from $250.00 to $250.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-007769 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,189,524

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective September 1, 2021) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-22-004617 · form4.xml · derivative · entry 5

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,815

Underlying: Common Stock · 20,939 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents shares acquired upon the vesting of the first installment of the RSUs noted in footnote 4 on February 10, 2022. The RSUs convert into common stock on a one-for-one basis.

F1 · derivative.expiration_date: Represents shares acquired upon the vesting of the first installment of the RSUs noted in footnote 4 on February 10, 2022. The RSUs convert into common stock on a one-for-one basis.

SEC source: 0001127602-22-004617 · form4.xml · derivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,754

Underlying: Common Stock · 83,754 shares

Expires not disclosed

F4 · derivative.exercise_date: These performance-based RSUs were awarded on February 10, 2021 and vest in four substantially equal annual installments, commencing on February 10, 2022. This represents the actual number of RSUs awarded after the performance metric was certified.

F4 · derivative.expiration_date: These performance-based RSUs were awarded on February 10, 2021 and vest in four substantially equal annual installments, commencing on February 10, 2022. This represents the actual number of RSUs awarded after the performance metric was certified.

SEC source: 0001127602-22-004617 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,189,502

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-22-004617 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,198,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon the vesting of the first installment of the RSUs noted in footnote 4 on February 10, 2022. The RSUs convert into common stock on a one-for-one basis.

SEC source: 0001127602-22-004617 · form4.xml · derivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,230

Underlying: Common Stock · 39,230 shares

Expires 2029-02-09

F3 · shares: These SARs become exercisable in four substantially equal annual installments, commencing on February 9, 2023.

F3 · derivative.exercise_date: These SARs become exercisable in four substantially equal annual installments, commencing on February 9, 2023.

SEC source: 0001127602-22-004305 · form4.xml · derivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,524 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 8, 2019. This represents the 2022 installment.

F1 · derivative.expiration_date: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 8, 2019. This represents the 2022 installment.

SEC source: 0001127602-22-004305 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,177,421

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-22-004305 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,185,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments, commencing on February 8, 2019. This represents the 2022 installment.